Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...

Edwards Lifesciences Corp. closed $22.48 below its 52-week high ($96.12), which the company reached on March 28th.

Bernstein analyst Lee Hambright raised the firm’s price target on Edwards Lifesciences (EW) to $74 from $72 and keeps a Market Perform rating ...

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty-six brokerages that are covering the stock, Ratings reports. Fifteen equities ...

BofA Securities has recently raised Edwards Lifesciences Corp (EW) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 11, 2024, Morgan Stanley had resumed ...

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Edwards Lifesciences (EW – Research Report) on January 6 and set a price ...

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on ...

BofA Securities has recently raised Edwards Lifesciences Corp (EW) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on October 11, 2024, Morgan Stanley had resumed ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

This was the stock's second consecutive day of gains.